Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Perreault L, Pan Q, Schroeder EB, Kalyani RR, Bray GA, Dagogo-Jack S, White NH, Goldberg RB, Kahn SE, Knowler WC, Mathioudakis N, Dabelea D; Diabetes Prevention Program Research Group.

Diabetes Care. 2019 Sep;42(9):1809-1815. doi: 10.2337/dc19-0244. Epub 2019 Jul 18.

PMID:
31320445
2.
3.

Mobility and Vitality Lifestyle Program (MOVE UP): A Community Health Worker Intervention for Older Adults With Obesity to Improve Weight, Health, and Physical Function.

Venditti EM, Zgibor JC, Vander Bilt J, Kieffer LA, Boudreau RM, Burke LE, Glynn NW, Jakicic JM, Smith KJ, Semler LN, Rager JR, Albert SM, Newman AB.

Innov Aging. 2018 Jun 18;2(2):igy012. doi: 10.1093/geroni/igy012. eCollection 2018 Jun.

4.

Impact of Race Versus Education and Race Versus Income on Patients' Motivation to Participate in Clinical Trials.

Kurt A, Kincaid H, Semler L, Jacoby JL, Johnson MB, Careyva BA, Stello B, Friel T, Smulian JC, Knouse MC.

J Racial Ethn Health Disparities. 2018 Oct;5(5):1042-1051. doi: 10.1007/s40615-017-0452-z. Epub 2017 Dec 26.

PMID:
29280106
5.

Factors Influencing Participation in Clinical Trials: Emergency Medicine vs. Other Specialties.

Kurt A, Kincaid HM, Curtis C, Semler L, Meyers M, Johnson M, Careyva BA, Stello B, Friel TJ, Knouse MC, Smulian JC, Jacoby JL.

West J Emerg Med. 2017 Aug;18(5):846-855. doi: 10.5811/westjem.2017.5.33827. Epub 2017 Jul 17.

6.

Gender Differences in CDC Guideline Compliance for STIs in Emergency Departments.

Kane BG, Guillaume AWD, Evans EM, Goyke TE, Eygnor JK, Semler L, Dusza SW, Greenberg MR.

West J Emerg Med. 2017 Apr;18(3):390-397. doi: 10.5811/westjem.2016.12.32440. Epub 2017 Mar 8.

7.

Research Professionals' Perspectives, Barriers, and Recommendations Regarding Minority Participation in Clinical Trials.

Kurt A, Semler L, Meyers M, Porter BG, Jacoby JL, Stello B.

J Racial Ethn Health Disparities. 2017 Dec;4(6):1166-1174. doi: 10.1007/s40615-016-0322-0. Epub 2016 Dec 21.

PMID:
28004355
8.

Racial Differences Among Factors Associated with Participation in Clinical Research Trials.

Kurt A, Semler L, Jacoby JL, Johnson MB, Careyva BA, Stello B, Friel T, Knouse MC, Kincaid H, Smulian JC.

J Racial Ethn Health Disparities. 2016 Sep 8. [Epub ahead of print]

PMID:
27631379
9.

Compliance with centers for disease control guidelines for ED patients with sexually transmitted diseases.

Evans EM, Goyke TE, Cohrac SA, Eygnor JK, Ward CJ, Semler L, Dusza SW, Greenberg MR, Kane BG.

Am J Emerg Med. 2016 Aug;34(8):1727-9. doi: 10.1016/j.ajem.2016.06.052. Epub 2016 Jun 13. No abstract available.

PMID:
27339222
10.

A Cross-Sectional Study of Medical Student Knowledge of Evidence-Based Medicine as Measured by the Fresno Test of Evidence-Based Medicine.

Smith AB, Semler L, Rehman EA, Haddad ZG, Ahmadzadeh KL, Crellin SJ, Falkowska K, Kendig KA, Steinweg BH, Dusza SW, Glenn-Porter B, Kane BG.

J Emerg Med. 2016 May;50(5):759-64. doi: 10.1016/j.jemermed.2016.02.006. Epub 2016 Mar 5.

PMID:
26961178
11.

Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.

Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC; Diabetes Prevention Program Research Group.

Psychosom Med. 2015 Apr;77(3):303-10. doi: 10.1097/PSY.0000000000000156.

12.

The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.

Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, Delahanty LM, Montez MG, Ackermann RT, Zhuo X, Knowler WC, Ratner RE; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2015 Apr;100(4):1646-53. doi: 10.1210/jc.2014-3761. Epub 2015 Feb 23.

13.

Prevention of Diabetes Through the Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to Practice.

Hoskin MA, Bray GA, Hattaway K, Khare-Ranade PA, Pomeroy J, Semler LN, Weinzierl VA, Wylie-Rosett J; for the Diabetes Prevention Program Research Group.

Curr Nutr Rep. 2014 Dec 1;3(4):364-378.

14.

Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.

Dabelea D, Ma Y, Knowler WC, Marcovina S, Saudek CD, Arakaki R, White NH, Kahn SE, Orchard TJ, Goldberg R, Palmer J, Hamman RF; Diabetes Prevention Program Research Group.

Diabet Med. 2014 Sep;31(9):1064-8. doi: 10.1111/dme.12437. Epub 2014 Apr 9.

15.

Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program.

Walford GA, Ma Y, Christophi CA, Goldberg RB, Jarolim P, Horton E, Mather KJ, Barrett-Connor E, Davis J, Florez JC, Wang TJ; Diabetes Prevention Program Research Group.

Diabetologia. 2014 May;57(5):935-9. doi: 10.1007/s00125-014-3183-2. Epub 2014 Feb 20.

16.

Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence.

Venditti EM, Wylie-Rosett J, Delahanty LM, Mele L, Hoskin MA, Edelstein SL; Diabetes Prevention Program Research Group.

Int J Behav Nutr Phys Act. 2014 Feb 12;11:16. doi: 10.1186/1479-5868-11-16.

17.

Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.

Franks PW, Christophi CA, Jablonski KA, Billings LK, Delahanty LM, Horton ES, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetologia. 2014 Mar;57(3):485-90. doi: 10.1007/s00125-013-3133-4. Epub 2013 Dec 7.

18.

Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study.

Marrero D, Pan Q, Barrett-Connor E, de Groot M, Zhang P, Percy C, Florez H, Ackermann R, Montez M, Rubin RR; DPPOS Research Group.

Qual Life Res. 2014 Feb;23(1):75-88. doi: 10.1007/s11136-013-0436-3. Epub 2013 May 26.

19.

Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.

Christophi CA, Resnick HE, Ratner RE, Temprosa M, Fowler S, Knowler WC, Shamoon H, Barrett-Connor E, Kahn SE; Diabetes Prevention Program Research Group.

J Diabetes Complications. 2013 Mar-Apr;27(2):150-7. doi: 10.1016/j.jdiacomp.2012.09.012. Epub 2012 Nov 7.

20.

Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.

Florez JC, Jablonski KA, McAteer JB, Franks PW, Mason CC, Mather K, Horton E, Goldberg R, Dabelea D, Kahn SE, Arakaki RF, Shuldiner AR, Knowler WC; Diabetes Prevention Program Research Group.

PLoS One. 2012;7(9):e44424. doi: 10.1371/journal.pone.0044424. Epub 2012 Sep 11.

Supplemental Content

Loading ...
Support Center